WASHINGTON (dpa-AFX) - Walgreens Boots Alliance, Inc. (WBA) made an
announcement on Wednesday about the launch of its own more affordable version of
the over-the-counter opioid overdose reversal spray naloxone.

This new product, Walgreens Brand Naloxone HCl Nasal Spray, is set to be
available both online and in all stores by the end of the month.

This move aims to address the opioid epidemic and the high rates of drug-related
fatalities in the United States by increasing the availability of this
life-saving medication.

The Walgreens Brand Naloxone HCl Nasal Spray is designed to temporarily reverse
the effects of opioids during an overdose, including heroin, illicit fentanyl,
and prescription opioid medications.

The spray works by blocking the effects of opioids on the brain, thereby
restoring normal breathing and preventing death.

Despite its effectiveness, access to naloxone is limited in many communities,
exacerbating the impact of the opioid epidemic. To tackle this issue, Walgreens
is making naloxone more accessible by offering it at a lower price than the
national brand equivalent in its stores.

Priced at $34.99, the product is available online now, with nationwide
availability in stores scheduled by the end of the month. It will be located in
the pain aisle, providing a crucial access point for the millions of individuals
served by Walgreens daily across the U.S.

According to the Centers for Disease Control and Prevention, naloxone is safe
for bystanders to administer during a suspected overdose and poses no harm if
the individual is not actually experiencing an overdose. This initiative by
Walgreens to increase the availability of naloxone has the potential to save
many lives and make a significant impact in combatting the opioid epidemic.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX